CDK5R1 and head and neck squamous cell carcinoma: In the present study, miR-21 inhibition was shown to reverse the EMT process in HNSCC cells by regulating CDK5/CDK5R1 (p35) with antisense oligonucleotide (asON) or a STAT3 inhibitor WP1066.